My Penn Genome (MPG)

Genomic biobanks embedded within medical systems have revolutionized genomic discovery and are poised to be a critical component of precision medicine. Genomic discoveries (e.g., polygenic risk scores) are routinely integrated into genetically informed risk assessments to increase performance of early disease interception/prevention, risk management and treatment evaluation. My Penn Genome (MPG) project aims to evaluate the integration of clinically-grade whole genome data joint with AI/ML for genomic discoveries to improve health outomes in Penn Medicine Biobank participants.